Search Results - "Sofia Menshikova"

Epstein–Barr virus-associated gastric cancer: disease that requires special approach by Ignatova, Ekaterina, Seriak, Daria, Fedyanin, Mikhail, Tryakin, Alexey, Pokataev, Ilya, Menshikova, Sofia, Vakhabova, Yuliya, Smirnova, Ksenia, Tjulandin, Sergey, Ajani, Jaffer A.

“…Epstein–Barr virus-associated gastric cancer [EBV-associated GC, EBV( +) GC] is a distinct molecular subtype of gastrointestinal (GI) cancers. It accounts for…”
Get full text

Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes by Emelyanova, Marina, Pudova, Elena, Khomich, Darya, Krasnov, George, Popova, Anna, Abramov, Ivan, Mikhailovich, Vladimir, Filipenko, Maxim, Menshikova, Sofia, Tjulandin, Sergey, Pokataev, Ilya

“…Background: Mutations in homologous recombination (HR) and Fanconi anemia (FA) genes may predispose to pancreatic cancer (PC) and enable the prediction of…”
Get full text

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis by Medford, Arielle J., Oshry, Lauren, Boyraz, Baris, Kiedrowski, Lesli, Menshikova, Sofia, Butusova, Anna, Dai, Charles S., Gogakos, Tasos, Keenan, Jennifer C., Occhiogrosso, Rachel H., Ryan, Phoebe, Lennerz, Jochen K., Spring, Laura M., Moy, Beverly, Ellisen, Leif W., Bardia, Aditya

“…Tissue-agnostic indications for targeted therapies have expanded options for patients with advanced solid tumors. The Food and Drug Administration approvals of…”
Get full text

Abstract PO2-15-12: Novel Transcriptomic Classification System Unveils HER2-Low Breast Tumors by Turova, Polina, Kushnarev, Vladimir, Baranov, Oleg, Butusova, Anna, Menshikova, Sofia, Yong, Sheila, Love, Anna, Chernyshov, Konstantin, Kotlov, Nikita

“…Abstract Breast cancers (BCs) are segregable into subtypes based on their intrinsic molecular features. When evaluating HER2 status, clinicians often rely on…”
Get full text

Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma by Ignatova, Ekaterina Olegovna, Kozlov, Evgenii, Ivanov, Maxim, Mileyko, Vladislav, Menshikova, Sofia, Sun, Henian, Fedyanin, Mikhail, Tryakin, Alexey, Stilidi, Ivan

“…Adenocarcinomas of the gastrointestinal tract (esophagus, stomach, and colon) represent a heterogeneous group of diseases with distinct etiology, clinical…”
Get full text

Abstract PO5-24-11: An integrated approach for comprehensive molecular and tumor microenvironment characterization of invasive lobular carcinoma by Mouabbi, Jason, Chernyshov, Konstantin, Baranov, Oleg, Kushnarev, Vladimir, Turova, Polina, Butusova, Anna, Menshikova, Sofia, Brown, Jessica, Kotlov, Nikita, Clayton, Patrick, Nomie, Krystle, Fowler, Nathan, Tripathy, Debu

“…Abstract Introduction: Although recent studies have shown that invasive lobular carcinoma (ILC) is associated with worse long-term outcomes compared to…”
Get full text

Abstract P5-02-13: TRK inhibitor in a patient with metastatic triple negative breast cancer and NTRK fusions identified via cell-free DNA analysis by Keenan, Jennifer C., Medford, Arielle J., Oshry, Lauren J., Boyraz, Baris, Dai, Charles S., Kiedrowski, Lesli A., Menshikova, Sofia, Butusova, Anna, Gogakos, Tasos, Occhiogrosso, Rachel, Ryan, Phoebe, Lennerz, Jochen, Spring, Laura M., Moy, Beverly, Ellisen, Leif, Bardia, Aditya

“…Abstract Introduction: Tissue-agnostic indications for targeted therapies are expanding options for patients with advanced solid tumors. The FDA approvals of…”
Get full text

TRK inhibitor in a patient with metastatic triple-negative breast cancer and fusions identified cell-free DNA analysis by Arielle J. Medford, Lauren Oshry, Baris Boyraz, Lesli Kiedrowski, Sofia Menshikova, Anna Butusova, Charles S. Dai, Tasos Gogakos, Jennifer C. Keenan, Rachel H. Occhiogrosso, Phoebe Ryan, Jochen K. Lennerz, Laura M. Spring, Beverly Moy, Leif W. Ellisen, Aditya Bardia

“…Tissue-agnostic indications for targeted therapies have expanded options for patients with advanced solid tumors. The Food and Drug Administration approvals of…”
Get full text

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis by Medford, Arielle J, Oshry, Lauren, Boyraz, Baris, Kiedrowski, Lesli, Menshikova, Sofia, Butusova, Anna, Dai, Charles S, Gogakos, Tasos, Keenan, Jennifer C, Occhiogrosso, Rachel H, Ryan, Phoebe, Lennerz, Jochen K, Spring, Laura M, Moy, Beverly, Ellisen, Leif W, Bardia, Aditya

Get full text